New drugs approved for use in Scottish NHS

The Scottish Medicines Consortium (SMC) has accepted the following new drugs for use within NHS Scotland:

  • Rotigotine (Neupro) for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults.
  • Etravirine (Intelence) for use in combination with a boosted protease inhibitor and other antiretroviral agents, to treat HIV-1 infection in antiretroviral-experienced adults.
  • Histrelin (Vantas) subcutaneous implant for restricted use in the palliative treatment of advanced prostate cancer.
  • Calcipotriol and betamethasone dipropionate scalp gel (Xamiol) for the topical treatment of scalp psoriasis.
  • Peginterferon alfa-2a (Pegasys) for use in combination with ribavirin to treat chronic hepatitis C in adults.

The SMC rejected degarelix (Firmagon) for the treatment of men with advanced hormone-dependent prostate cancer.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more